Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma
Clinical trial NCT01636388 · TERMINATED
Trial details
- NCT number
- NCT01636388
- Sponsor
- New York Medical College
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2017-06-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.